Dual PET/CT Imaging in Lung Cancer
NCT01539928 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 216
Last updated 2013-06-25
Summary
The purpose of this study is to compare conventional PET/CT scan performed 1 hour after injection of the radioactive tracer FDG (PET/CT\[1\]) with PET/CT performed after 3 hours (PET/CT\[3\]) in a group of patients with biopsy verified lung cancer or high suspicion of lung cancer after initial work-up (chest x-ray and CT of thorax/upper abdomen), who are potentially operable.
Conditions
Interventions
- OTHER
-
Dual FDG-PET/CT
Conventional FDG-PET/CT preformed after 1 hour and additional PET/CT 3 hours after injection
Sponsors & Collaborators
-
Odense University Hospital
lead OTHER
Principal Investigators
-
Mie H Vilstrup, MD · Odense University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2014-03-31
- Completion
- 2015-03-31
Countries
- Denmark
Study Locations
More Related Trials
-
Early Versus Late FDG-PET/CT in Bladder Cancer
NCT03065725 ·Status: COMPLETED
-
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NCT06082492 ·Status: RECRUITING ·Phase: NA
-
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer
NCT02995889 ·Status: COMPLETED ·Phase: NA
-
PET Response During Chemoradiation of Lung Cancer
NCT02315053 ·Status: COMPLETED ·Phase: NA
-
The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients
NCT04395651 ·Status: UNKNOWN
-
Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy
NCT02608528 ·Status: TERMINATED
-
Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer
NCT01889615 ·Status: UNKNOWN
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
PET/CT and Sentinel Node in Oral Cancer
NCT01136265 ·Status: UNKNOWN
-
Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival
NCT01261598 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
NCT00004138 ·Status: COMPLETED ·Phase: NA
-
Dual Time Point PET in Lymphoma
NCT01894945 ·Status: UNKNOWN
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
NCT00392938 ·Status: COMPLETED
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma
NCT02931201 ·Status: UNKNOWN ·Phase: NA
-
PET CT Re-Planning NSCLC (4DCT-PET)
NCT03403127 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer
NCT00310219 ·Status: COMPLETED ·Phase: NA
-
PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases
NCT00382252 ·Status: COMPLETED ·Phase: NA
-
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
NCT00201942 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma
NCT03051542 ·Status: UNKNOWN ·Phase: NA
-
Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00227539 ·Status: COMPLETED ·Phase: PHASE2
-
FDG PET/CT in Lung Cancer Staging
NCT02738398 ·Status: COMPLETED ·Phase: NA
-
Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma
NCT00188929 ·Status: COMPLETED ·Phase: PHASE2